# Safety and Efficacy of SPD489 on Executive Function Behaviors in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)

> **NCT01101022** · PHASE4 · COMPLETED · sponsor: **Shire** · enrollment: 161 (actual)

## Conditions studied

- ADHD Specifically With Executive Function Impairment

## Interventions

- **DRUG:** SPD489
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT01101022
- **Lead sponsor:** Shire
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-05-19
- **Primary completion:** 2010-11-29
- **Final completion:** 2010-11-29
- **Target enrollment:** 161 (ACTUAL)
- **Last updated:** 2021-06-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01101022

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01101022, "Safety and Efficacy of SPD489 on Executive Function Behaviors in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01101022. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*